Medicon Village
Scheelevägen 8
Lund 223 63
Sweden
46 4 62 75 60 00
https://www.immunovia.com
Sector(s):
Industry:
Full-time employees: 11
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Jeff Borcherding | Global Chief Executive Officer & President | N/A | N/A | 1973 |
Ms. Karin Almqvist Liwendahl | Chief Financial Officer | N/A | N/A | 1962 |
Dr. Karl M. Stone | Chief Operating Officer | N/A | N/A | 1963 |
Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs | N/A | N/A | N/A |
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Immunovia AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.